Publications
& Posters

We are proud to contribute to the latest cancer research through scientific publications and medical meetings.

March 2017

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Mesa et al. Lancet Haematology, March 2017

WORKING TOGETHER TO MAKE A DIFFERENCE FOR PATIENTS